Jazz Pharmaceuticals
JAZZ
#2012
Rank
NZ$14.13 B
Marketcap
$233.75
Share price
-2.09%
Change (1 day)
12.64%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.13

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.46. In 2022 the company made an earnings per share (EPS) of -$6.18 an increase over its 2021 EPS that were of -$9.39.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-65.5%
2022-$6.18-34.2%
2021-$9.39-224.83%
2020$7.52-53.25%
2019$16.0923.59%
2018$13.02-8.24%
2017$14.1923.74%
2016$11.4622.12%
2015$9.39478.49%
2014$1.62-74.93%
2013$6.47-27.11%
2012$8.8869.1%
2011$5.25245.98%
2010$1.52-462.5%
2009-$0.42-96.7%
2008-$12.70-27.04%
2007-$17.4165.47%
2006-$10.52-4.59%
2005-$11.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$7.01 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$14.47-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.53-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.49 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel